Telehealth companies Hims & Hers Health Inc., Noom Inc. and Sesame Inc. have lured individual customers with low-cost versions of popular weight-loss shots like Ozempic and Wegovy. Now, they’re going after employers, too, as the medications become an in-demand perk.
After Noom began offering a compounded copy of Wegovy for $149 a month, Chief Executive Officer Geoff Cook said he was “actually a little surprised” by the level of employer interest. “The announcement seemed to bring folks out of the woodwork,” Cook said in an interview. “They were clearly already investigating if this could be a solution for their employees.”
Though Noom had offered brand-name versions of drugs like Ozempic since May 2023, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
